Cited by 25Neonatal and fetal brain pathologyNeonatal Health and BiochemistryFetal and Pediatric Neurological Disorders

Umbilical cord blood concentrations of ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) in neonates developing hypoxic-ischemic encephalopathy

Zaigham, Mehreen, Lundberg, Fredrik, Hayes, Ronald, Undén, Johan, Olofsson, Per·2015·The Journal of Maternal-Fetal & Neonatal Medicine

Abstract

OBJECTIVE: To compare ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) concentrations in umbilical cord blood of neonates who develop Sarnat stage II-III hypoxic-ischemic encephalopathy (HIE) to healthy controls, and to relate the concentrations to the severity of neurology and long-time outcomes. MATERIAL AND METHODS: Cord sera of 15 neonates with HIE II-III and 31 matched controls were analyzed for UCH-L1 and GFAP. Comparisons were performed for cord artery pH, amplitude-integrated electroencephalography (aEEG), stage of HIE, and death or sequelae up to an age of 6 years. Parametric and non-parametric statistics were used with a two-sided p < 0.05 considered significant. RESULTS: Among controls no associations between biomarker concentrations and gestational age, birthweight, length of storage of cord sera and degree of hemolysis were found. No significant differences in biomarker concentrations were found between HIE neonates and controls, and no differences were found with regard to HIE stage, cord acidemia, severity of aEEG changes, or persistent sequelae or death. CONCLUSIONS: No differences in cord blood UCH-L1 and GFAP concentrations were found between HIE neonates and controls, and no associations were found between the biomarker concentrations and the severity of disease, or whether the condition developed into a permanent or fatal injury.

Integrity signals

Registry

Crossref · 10.3109/14767058.2015.1064108

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a series of neonates with HIE stages 2 and 3, the authors found no differences in cord blood UCH-L1 and GFAP concentrations relative to healthy controls, and no associations of biomarker concentrations with severity of disease or with development of the condition into a permanent or fatal injury.

    “We found in a series of neonates with HIE stages 2 and 3 no differences in cord blood UCH-L1 and GFAP concentrations relative to healthy controls, and no associations of biomarker concentrations with severity of disease or with development of the condition into a permanent or fatal injury.124”
  • LDH determined early in the course has low or no predictive value.

    “temporal blood sampling studies 124,127 indicate that LDH determined early in the course has low or no predictive value.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zaigham, M., Lundberg, F., Hayes, R., Undén, J., & Olofsson, P.
Affiliations
  • Lund University (SE)
  • Banyan Biomarkers (United States) (US)
Corresponding author
Olofsson, Per
Venue
The Journal of Maternal-Fetal & Neonatal Medicine
Published
2015-07-02
Volume
29
Issue
11
Pages
1-7
ISSN
  • 1476-4954 (ISSN-L)
  • 1476-7058
OpenAlex
W1777352419
Cited by
25
References
24
Citations by year
2026: 2 · 2025: 1 · 2024: 3 · 2023: 4 · 2022: 4 · 2021: 1 · 2019: 4 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 1
FWCI
2.00
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Maternal-Fetal & Neonatal Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
Funders
Lunds Universitet
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and fetal brain pathology
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal Health and Biochemistry
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Fetal and Pediatric Neurological Disorders
Keywords
hypoxic-ischemic encephalopathy, UCHL1, glial fibrillary acidic protein, umbilical cord blood, neonatal biomarkers, Sarnat staging, neuroprognostic biomarkers, long-term neurological outcome, amplitude-integrated electroencephalography
MeSH terms
Acidosis, Birth Weight, Female, Fetal Blood, Gestational Age, Glial Fibrillary Acidic Protein, Hemolysis, Humans, Infant, Newborn, Male, Specimen Handling, Biomarkers, Case-Control Studies, Hypoxia-Ischemia, Brain, Ubiquitin Thiolesterase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review